In agreement with these findings, Xiao et al. [74] by in vitro and in vivo studies showed that, in status of NASH progression, the MDA production increased, while the protein expression of SOD and GPx suppressed. The gene discussed is SOD1; the disease is metabolic dysfunction-associated steatohepatitis.